1PARK B B, PARK J O, LEE H R, et al. A phase Ⅱ trial of gemcitabine plus capecitabine for patients with advanced pancreatic adenocarcinoma[ J ]. Cancer Chemother Pharmacol, 2007, 60 (4) : 489 - 494.
3TOGAWA A, YOSHITOMI H, ITO H, et al. Treatment with an oral fluoropyrimidine, S- 1, plus cisplatin in patients who failed postoperative gemcitabine treatment for pancreatic cancer: a pilot study[J]. Int J Clin Oncol, 2007, 12(4) : 268 -273.
4LEE G W, KIM H J, JU J H, et al. Phase II trial of S - 1 in combination with gemcitabine for chemo - naive patients with locally advanced or metastatic pancreatic cancer[J]. Cancer Chemother Pharmacol, 2009, 64 (4) : 707 - 713.
5KRALIDIS E, AEBI S, FRIESS H, et al. Activity of raltitrexed and gemcitabine in advanced pancreatic cancer[ J]. Ann Oncol, 2003, 14(4) : 574 -579.
6BOECK S, WEIGANG - KOHLER K, FUCHS M, et al. Second - line chemotherapy with pemetrexed after gemcitabine failure in patients with advanced pancreatic cancer: a muhicenter phase Ⅱ trial[J]. Ann Oncol, 2007, 18(4) : 745 -751.
7OETTLE H, RICHARDS D, RAMANATHAN R K, et al. A phase Ⅲ trial of pemetrexed plus gemcitabine versus gemcitabine in patients with unresectable or metastatic pancreatic cancer [ J ]. Ann Oncol, 2005, 16(10) : 1639 - 1645.
8STEPHENS C D. Gemcitabine: a new approach to treating pancreatic cancer[ J]. Oncol Nurs Forum, 1998, 25 (1) : 87 -93.
9BANU E, BANU A, FODOR A, et al. Meta - analysis of randomised trials comparing gemcitabine - based doublets versus gemcitabine alone in patients with advanced and metastatic pancreatic cancer[J]. Drug Aging, 2007, 24(10): 865-879.
10Palmer D H, Stocken D D, Hewitt H, et al. A randomized phase 2 trial of neoadjuvant chemotherapy in resectable pancreatic cancer: gemcitabine alone versus gemcitabine combined with cisplatin [J]. Ann Surg Oncol, 2007, 14(7) : 2088 -2096.
